Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1099-1118 , December 2006

Lyme borreliosis

  • Sebastian Schnarr, MD (Consultant Rheumatologist, Director of the Rheumaklinik Ostbayern, Bad Fuessing)
  • Juliane K. Franz, MD (Consultant Rheumatologist, Director of the Privatklinik im Park, Bad Schinznach)
  • Andreas Krause, MD, PhD (Professor of Medicine, Consultant Rheumatologist, Director of Rheumakliniken Berlin-Buch and Berlin-Wannsee)
  • Henning Zeidler, MD, PhD (Professor of Medicine, Consultant Rheumatologist, Director of the Division of Rheumatology, Medical School Hannover)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 511 532 2191; Fax: +49 511 532 5841.

References 

  1. Steere AC. Lyme disease. New England Journal of Medicine. 2001;345:115–125
  2. Weber K. Aspects of Lyme borreliosis in Europe. European Journal of Clinical Microbiology & Infectious Diseases. 2001;20:6–13
  3. Franz JK, Krause A. Lyme disease (Lyme borreliosis). Best Practice Research. Clinical Rheumatology. 2003;17:241–264
  4. Campbell GL, Fritz CL, Fish D, et al. Estimation of the incidence of Lyme disease. American Journal of Epidemiology. 1998;148:1018–1026
  5. Centers for Disease Control and Prevention . Lyme disease – United States, 2001–2002. Morbidity and Mortality Weekly Report. 2004;53:365–369
  6. Stanek G, Satz N, Strle F, Wilske B. Epidemiology of Lyme borreliosis. In:  Weber K,  Burgdorfer W editor. Aspects of Lyme borreliosis. Berlin: Springer; 1993;p. 358–370
  7. Strle F. Lyme borreliosis in Slovenia. Zentralblatt für Bakteriologie. 1999;289:643–652
  8. Smith R, O'Connell S, Palmer S. Lyme disease surveillance in England and Wales, 1986–1998. Emerging Infectious Diseases. 2000;6:404–407
  9. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639–1647
  10. Letrilliart L, Ragon B, Hanslik T, Flahault A. Lyme disease in France: a primary care-based prospective study. Epidemiology and Infection. 2005;133:935–942
  11. Piacentino JD, Schwartz BS. Occupational risk of Lyme disease: an epidemiological review. Occupational and Environmental Medicine. 2002;59:75–84
  12. Wilske B. Epidemiology and diagnosis of Lyme borreliosis. Annals of Medicine. 2005;37:568–579
  13. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clinical Microbiology and Infection. 1996;3:109–116
  14. Diza E, Papa A, Vezyri E, et al. Borrelia valaisiana in cerebrospinal fluid. Emerging Infectious Diseases. 2004;10:1692–1693
  15. Wang G, van Dam AP, Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from patients with borreliosis. Journal of Clinical Microbiology. 1999;37:3025–3028
  16. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. Journal of Clinical Investigations. 2004;113:1093–1101
  17. Hu L. Lyme arthritis. Infectious Disease Clinics of North America. 2005;19:947–961
  18. Schwan TG, Piesman J. Temporal changes in outer surface proteins A and C of the Lyme disease associated spirochete, Borrelia burgdorferi. Journal of Clinical Microbiology. 2000;38:382–388
  19. Duray PH, Steere AC. Clinical pathologic correlation of Lyme disease by stage. Annals of the New York Academy of Sciences. 1988;539:65–79
  20. Kraizcy P, Skerka C, Kirschfink M, et al. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. European Journal of Immunology. 2001;31:1674–1684
  21. Labandeira-Rey M, Skare JT. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Molecular Microbiology. 2003;48:446–455
  22. Liang FT, Brown EL, Wang T, et al. Protective niche for Borrelia burgdorferi to evade humoral immunity. American Journal of Pathology. 2004;165:977–985
  23. Priem S, Burmester GR, Kamradt T, et al. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Annals of Rheumatic Diseases. 1998;57:118–121
  24. Steere AC, Klitz W, Drouin EE, et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. Journal of Experimental Medicine. 2006;203:961–971
  25. Steere AC, Falk B, Drouin EE, et al. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis and Rheumatism. 2003;48:534–540
  26. Ghosh S, Steere AC, Stollar BD, Huber BT. In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. Journal of Immunology. 2005;174:2860–2869
  27. Halperinn JJ. Central nervous system Lyme disease. Current Neurology and Neuroscience Reports. 2005;5:446–452
  28. Müllegger RR. Dermatological manifestations of Lyme borreliosis. European Journal of Dermatology. 2004;14:296–309
  29. Centers for Disease Control and Prevention . Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. Morbidity and Mortality Weekly Report. 1995;44:590–591
  30. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clinical Microbiology Reviews. 2005;18:484–509
  31. Wilske B, Fingerle V, Herzer P, et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Medical Microbiology and Immunology. 1993;182:255–270
  32. Liang FT, Steere AC, Marques AR, et al. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. Journal of Clinical Microbiology. 1999;37:3990–3996
  33. Philipp MT, Bowers LC, Fawcett PT, et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. Journal of Infectious Diseases. 2001;184:870–878
  34. Zore A, Ruzic-Sabljic E, Maraspin V, et al. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wiener klinische Wochenschrift. 2002;114:606–609
  35. Wormser GP, Bittker S, Cooper D, et al. Yield of large-volume blood cultures in patients with early Lyme disease. Journal of Infectious Diseases. 2001;184:1070–1072
  36. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. Journal of Clinical Microbiology. 1990;28:473–479
  37. Karch H, Huppertz HI, Bohme M, et al. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. Journal of Clinical Microbiology. 1994;32:2312–2314
  38. Nocton JJ, Dressler F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. New England Journal of Medicine. 1994;330:229–234
  39. Dinser R, Jendro MC, Schnarr S, Zeidler H. Antibiotic treatment of Lyme borreliosis: what is the evidence?. Annals of the Rheumatic Diseases. 2005;64:519–523
  40. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Annals of Internal Medicine. 1992;117:273–280
  41. Dattwyler RJ, Volkman DJ, Conaty SM, et al. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 1990;336:1404–1406
  42. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrobial Agents and Chemotherapy. 1995;39:661–667
  43. Strle F, Ruzic E, Cimperman J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. The Journal of Antimicrobial Chemotherapy. 1992;30:543–550
  44. Strle F, Preac-Mursic V, Cimperman J, et al. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection. 1993;21:83–88
  45. Barsic B, Maretic T, Majerus L, Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection. 2000;28:153–156
  46. Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics. 2002;109:1173–1177
  47. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Annals of Internal Medicine. 1996;124:785–791
  48. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993;21:367–372
  49. Hansen K, Hovmark A, Lebech AM, et al. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta dermato-venereologica. 1992;72:297–300
  50. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis and Rheumatism. 1994;37:878–888
  51. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. New England Journal of Medicine. 1997;337:289–294
  52. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis – randomised comparison of ceftriaxone and penicillin. Lancet. 1988;1:1191–1194
  53. Hassler D, Zoller L, Haude M, et al. Cefotaxime versus penicillin in the late stage of Lyme disease – prospective, randomized therapeutic study. Infection. 1990;18:16–20
  54. O'Dell JR, Elliott JR, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis and Rheumatism. 2006;54:621–627
  55. Weber K, Preac-Mursic V, Neubert U, et al. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Annals of the New York Academy of Sciences. 1988;539:324–345
  56. Kindstrand E, Nilsson BY, Hovmark A, et al. Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment. Acta Neurologica Scandinavica. 2002;106:253–257
  57. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clinical Infectious Diseases. 1999;28:569–574
  58. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology. 1994;44:1203–1207
  59. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. Journal of Neurology. 1989;236:464–469
  60. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scandinavian Journal of Infectious Diseases. 2005;37:449–454
  61. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clinical Infectious Diseases. 2000;31(supplement 1):1–14
  62. Hassler D, Riedel K, Zorn J, Preac-Mursic V. Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis. Lancet. 1991;338:193
  63. Gasser RN, Reisinger EC, Eber B, et al. Treatment of late Lyme borreliosis with cefoperazone and sulbactam. Lancet. 1995;345:586
  64. Patel R, Grogg KL, Edwards WD, et al. Death from inappropriate therapy for Lyme disease. Clinical Infectious Diseases. 2000;31:1107–1109
  65. Hunfeld KP, Ruzic-Sabljic E, Norris DE, et al. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy. 2005;49:1294–1301
  66. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine. 2001;345:85–92
  67. Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch–Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. New England Journal of Medicine. 1996;335:311–315
  68. Cimmino MA, Moggiana GL, Parisi M, Accardo S. Treatment of Lyme arthritis. Infection. 1996;24:91–93
  69. Weissenbacher S, Ring J, Hofmann H. Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study. Dermatology. 2005;211:123–127
  70. Nentwig G. Use of repellents as prophylactic agents. Parasitology Research. 2003;90(supplement 1):S40–S48
  71. Meiners T, Hammer B, Gobel UB, Kahl O. Determining the tick scutal index allows assessment of tick feeding duration and estimation of infection risk with Borrelia burgdorferi sensu lato in a person bitten by an Ixodes ricinus nymph.. International Journal of Medical Microbiology. 2006;296(supplement 40):103–107
  72. Kamradt T. Lyme disease and current aspects of immunization. Arthritis Research. 2002;4:20–29
  73. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. New England Journal of Medicine. 1992;327:1769–1773
  74. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New England Journal of Medicine. 2001;345:79–84
  75. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998;281:703–706

PII: S1521-6942(06)00110-0

doi: 10.1016/j.berh.2006.08.006

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1099-1118 , December 2006

Article Tools